n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with sirolimus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altay, O; Flores, JJ; Klebe, D; Lekic, T; Manaenko, A; McBride, DW; Rolland, WB; Tang, J; Zhang, JH | 1 |
1 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and sirolimus
Article | Year |
---|---|
Protease-activated receptor 1 and 4 signal inhibition reduces preterm neonatal hemorrhagic brain injury.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Brain Injuries; Cerebral Hemorrhage; Cyclooxygenase 2; Immunosuppressive Agents; Nitrobenzenes; Rats; Receptor, PAR-1; Receptors, Thrombin; Signal Transduction; Sirolimus; Sulfonamides | 2015 |